PuSH - Publikationsserver des Helmholtz Zentrums München: Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Stacey, D.* ; Chen, L.* ; Stanczyk, P.J.* ; Howson, J.M.M.* ; Mason, A.M.* ; Burgess, S.* ; MacDonald, S.* ; Langdown, J.* ; McKinney, H.* ; Downes, K.* ; Farahi, N.* ; Peters, J.E.* ; Basu, S.* ; Pankow, J.S.* ; Tang, W.* ; Pankratz, N.* ; Sabater-Lleal, M.* ; de Vries, P.S.* ; Smith, N.L.* ; CHARGE Hemostasis Working Group (Peters, A.) ; Gelinas, A.D.* ; Schneider, D.J.* ; Janjic, N.* ; Samani, N.J.* ; Ye, S.* ; Summers, C.* ; Chilvers, E.R.* ; Paul, D.S.*

Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus.

Nat. Commun. 13:1222 (2022)

Verlagsversion

Forschungsdaten

DOI

PMC

	Open Access Gold

Abstract
Metriken
Zusatzinfos

Many individual genetic risk loci have been associated with multiple common human diseases. However, the molecular basis of this pleiotropy often remains unclear. We present an integrative approach to reveal the molecular mechanism underlying the PROCR locus, associated with lower coronary artery disease (CAD) risk but higher venous thromboembolism (VTE) risk. We identify PROCR-p.Ser219Gly as the likely causal variant at the locus and protein C as a causal factor. Using genetic analyses, human recall-by-genotype and in vitro experimentation, we demonstrate that PROCR-219Gly increases plasma levels of (activated) protein C through endothelial protein C receptor (EPCR) ectodomain shedding in endothelial cells, attenuating leukocyte-endothelial cell adhesion and vascular inflammation. We also associate PROCR-219Gly with an increased pro-thrombotic state via coagulation factor VII, a ligand of EPCR. Our study, which links PROCR-219Gly to CAD through anti-inflammatory mechanisms and to VTE through pro-thrombotic mechanisms, provides a framework to reveal the mechanisms underlying similar cross-phenotype associations.

Impact Factor

Scopus SNIP

Altmetric

17.694

3.341